| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -10% |
| 3Y CAGR | +11% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +41% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,793.90 -8.60 (0.18%) | 21,951.13 | 29.86 | 5.22 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,517.90 +1.60 (0.06%) | 19,147.35 | 28.24 | 5.34 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,110.00 -43.00 (0.60%) | 17,888.63 | 105.46 | 20.5 | ||
Natco PharmaNATCOPHARM | ₹859.15 -4.25 (0.49%) | 15,465.24 | 13.51 | 1.68 |